Development of CRISPR/Cas Genome Editing as a Treatment for Ataxia Telangiectasia

Project: Research

Project Details

StatusActive
Effective start/end date1/11/17 → 11/03/25

Funding

  • Action for AT: £200,000.00
  • Action for AT: £40,000.00